Oxygen Ingress: The Silent Threat to Parenteral Stability and Product Integrity
The stability of a drug product in parenteral manufacturing is inextricably linked to the primary packaging’s ability to maintain a strictly controlled internal atmosphere. For pharmaceutical executives and quality leads, failure in headspace control is far more than a technical glitch; it is an operational risk that directly threatens patient safety and regulatory standing. Oxygen […]